Evidence map›Paper›PMID 40750702›Full record

ArticleThe EMBO journal2025

NRAC controls CD36-mediated fatty acid uptake in adipocytes and lipid clearance in vivo.

Inderjeet Singh, Yasuhiro Onogi, Filipe Menezes, Dina Khasanova, Lingru Kang, Chenxi Wang, Julio Ruiz-Trave, Sapna Sharma, Ahmed Khalil, Valentin K Reichenbach and 27 more

Abstract read
In one paragraph

Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Peptide-functionalized nanoemulsions with exendin-4 as a model ligand.International journal of pharmaceutics: X · 2026
    Article
  2. Review
  3. Reciprocal adipose-heart regulation of NRAC.bioRxiv : the preprint server for biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Inderjeet SinghResearch Unit Adipocytes & Metabolism (ADM), Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, 85764, Germany.
Yasuhiro OnogiResearch Unit Adipocytes & Metabolism (ADM), Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, 85764, Germany.ORCID http://orcid.org/0000-0002-7950-8952
Filipe MenezesMolecular Targets and Therapeutics Center, Institute of Structural Biology, Neuherberg, 85764, Germany.ORCID http://orcid.org/0000-0002-7630-5447
Dina KhasanovaMolecular Targets and Therapeutics Center, Institute of Structural Biology, Neuherberg, 85764, Germany.
Lingru KangResearch Unit Adipocytes & Metabolism (ADM), Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, 85764, Germany.
Chenxi WangResearch Unit Adipocytes & Metabolism (ADM), Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, 85764, Germany.
Julio Ruiz-TraveGerman Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.ORCID http://orcid.org/0009-0002-5752-7527
Sapna SharmaGerman Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.ORCID http://orcid.org/0000-0003-1039-8879
Ahmed KhalilResearch Unit Adipocytes & Metabolism (ADM), Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, 85764, Germany.ORCID http://orcid.org/0009-0000-2204-8636
Valentin K ReichenbachResearch Unit Adipocytes & Metabolism (ADM), Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, 85764, Germany.ORCID http://orcid.org/0009-0004-4115-6201
Yingzi ShiResearch Unit Adipocytes & Metabolism (ADM), Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, 85764, Germany.
Andrew FlatleyCore Facility Monoclonal Antibodies (CF-MAB), Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, 85764, Germany.
Xiaocheng YanResearch Unit Adipocytes & Metabolism (ADM), Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, 85764, Germany.
Andreas IsraelResearch Unit Adipocytes & Metabolism (ADM), Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, 85764, Germany.
Nathalia R V DraganoGerman Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.ORCID http://orcid.org/0000-0002-6856-5468
Juan Antonio Aguilar-PimentelInstitute of Experimental Genetics, German Mouse Clinic, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, 85764, Germany.
Anne HoffmannHelmholtz Institute for Metabolic, Obesity and Vascular Research (HI-MAG), Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany.
Adhideb GhoshInstitute of Food, Nutrition and Health, ETH Zurich, Schwerzenbach, 8092, Switzerland.ORCID http://orcid.org/0000-0002-5160-4571
Falko NoéInstitute of Food, Nutrition and Health, ETH Zurich, Schwerzenbach, 8092, Switzerland.ORCID http://orcid.org/0009-0002-3360-5455
Christian WolfrumInstitute of Food, Nutrition and Health, ETH Zurich, Schwerzenbach, 8092, Switzerland.ORCID http://orcid.org/0000-0002-3862-6805
Sebastian CucuruzGerman Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.
Ann-Christine KönigMetabolomics and Proteomics Core (MPC), Helmholtz Center Munich, Neuherberg, Germany.
Ingo BurtscherGerman Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.ORCID http://orcid.org/0000-0002-0635-3507
Stefanie M HauckMetabolomics and Proteomics Core (MPC), Helmholtz Center Munich, Neuherberg, Germany.ORCID http://orcid.org/0000-0002-1630-6827
Heiko LickertGerman Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.
Susanna M HofmannGerman Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.ORCID http://orcid.org/0000-0001-7682-5840
Regina FeederleCore Facility Monoclonal Antibodies (CF-MAB), Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, 85764, Germany.ORCID http://orcid.org/0000-0002-3981-367X
Sonja C SchrieverGerman Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.ORCID http://orcid.org/0000-0001-5461-3214
Rene Hernandez-BautistaResearch Unit Adipocytes & Metabolism (ADM), Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, 85764, Germany.ORCID http://orcid.org/0000-0001-7065-2862
Gencer SancarGerman Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.ORCID http://orcid.org/0000-0002-2098-0654
Alberto Cebrian-SerranoGerman Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.
Igor TetkoMolecular Targets and Therapeutics Center, Institute of Structural Biology, Neuherberg, 85764, Germany.ORCID http://orcid.org/0000-0002-6855-0012
Helmut FuchsGerman Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.
Valérie Gailus-DurnerGerman Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.
Matthias BlüherGerman Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.
Martin Hrabě de AngelisGerman Center for Diabetes Research (DZD), Neuherberg, 85764, Germany.
Siegfried UssarResearch Unit Adipocytes & Metabolism (ADM), Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health GmbH, Neuherberg, 85764, Germany. siegfried.ussar@helmholtz-munich.de.ORCID http://orcid.org/0000-0001-7575-0920

Funding

Deutsche Forschungsgemeinschaft (DFG) 209933838Deutsches Zentrum für Diabetesforschung (DZD) 82DZD00601EC | Horizon Europe | Excellent Science | HORIZON EUROPE Marie Sklodowska-Curie Actions (MSCA) 101120466Federal Ministry of Education and Research 01KX1012Uehara Memorial Foundation (UMF) 201830047
6 · The paper itself

Abstract

Adipose tissue is a central organiser of systemic lipid homeostasis and a pharmacological target in obesity, orchestrating cellular responses to environmental cues. Nutritionally regulated adipose and cardiac enriched protein (NRAC) is a small adipocyte-specific transmembrane protein with unknown function. Here, we show that Nrac directly interacts with scavenger receptor CD36 via its first transmembrane domain. Forming a complex with CD36 and caveolin-1 under low extracellular fatty acid (FA) concentrations, NRAC modulates CD36-dependent fatty acid uptake in adipocytes. Upon increase in extracellular FA levels, NRAC is ubiquitinated and internalised, leading to CD36's dissociation from caveolin-1 and clathrin-mediated endocytosis. This results in increased fatty acid uptake into fat cells, adipocyte hypertrophy, increased fat mass and elevated lipid clearance from the blood in chow-diet-fed mice. Finally, human NRAC expression and the intronic SNP rs12878589 are associated with body fat distribution and obesity. Together, these findings reveal a novel regulatory mechanism by which adipocytes sense and respond to extracellular fatty acid availability to fine-tune lipid uptake and storage at cellular and organismal level.

Indexed as

AdipocytesCD36 AntigensFatty AcidsLipid Metabolism3T3-L1 CellsAnimalsHumansMaleMiceMice, Inbred C57BLObesityCD36 AntigensCD36 protein, humanCd36 protein, mouseFatty AcidsAdipose TissueCD36Clathrin-mediated EndocytosisFatty Acid UptakeHypertrophy

Identifiers

PMID40750702
PMCPMC12436663

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.